The global Obesity Management market size was valued at USD 5695.6 million in 2023 and is forecast to a readjusted size of USD 7781.1 million by 2030 with a CAGR of 4.6% during review period.
Lifestyle diseases such as diabetes and other chronic ailments are the main cause of obesity around the world. Improved healthcare and medical facilities have led to an increase in the life expectancy of people, which is the primary reason for the large geriatric population seen in the developed world. Geriatric people are far more prone to conceal sarcopenia i.e. a noticeable rise in body fat with simultaneous loss of muscle mass and functional capability.
According to public information, in 2022, there were about 1.2 billion obesity cases worldwide, among them, the number of obesity cases in China reached 230 million. Wellness & Health Research Center, the global sports economy was valued at 750 billion in 2022, 92% of global spending on physical activity occurs in Asia Pacific, North America and Europe. And China and the United States accounted for 44% of total sports spending.
This report includes an overview of the development of the Obesity Management industry chain, the market status of Hospitals (Drug, Surgery), Speciality Clinics (Drug, Surgery), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Obesity Management.
Regionally, the report analyzes the Obesity Management markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Obesity Management market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Obesity Management market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Obesity Management industry.
The report involves analyzing the market at a macro level:
麻豆原创 Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Drug, Surgery).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Obesity Management market.
Regional Analysis: The report involves examining the Obesity Management market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
麻豆原创 Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Obesity Management market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Obesity Management:
Company Analysis: Report covers individual Obesity Management players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Obesity Management This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Speciality Clinics).
Technology Analysis: Report covers specific technologies relevant to Obesity Management. It assesses the current state, advancements, and potential future developments in Obesity Management areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Obesity Management market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
麻豆原创 Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
麻豆原创 Segmentation
Obesity Management market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
麻豆原创 segment by Type
Drug
Surgery
麻豆原创 segment by Application
Hospitals
Speciality Clinics
Ambulatory Surgical Centres
Retail Pharmacies
麻豆原创 segment by players, this report covers
Allergan
Allurion Technologies
Arena Pharmaceuticals
Beijing Noble Laser Technology
Eisai
GlaxoSmithKline
Johnson & Johnson
Medtronic
Nalpropion Pharmaceuticals
Novo Nordisk
Obalon Therapeutics
Orexigen Therapeutics
ReShape Lifesciences
Roche
VIVUS
麻豆原创 segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Obesity Management product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Obesity Management, with revenue, gross margin and global market share of Obesity Management from 2019 to 2024.
Chapter 3, the Obesity Management competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Obesity Management market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Obesity Management.
Chapter 13, to describe Obesity Management research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 麻豆原创 Overview
1.1 Product Overview and Scope of Obesity Management
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 Classification of Obesity Management by Type
1.3.1 Overview: Global Obesity Management 麻豆原创 Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Obesity Management Consumption Value 麻豆原创 Share by Type in 2023
1.3.3 Drug
1.3.4 Surgery
1.4 Global Obesity Management 麻豆原创 by Application
1.4.1 Overview: Global Obesity Management 麻豆原创 Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospitals
1.4.3 Speciality Clinics
1.4.4 Ambulatory Surgical Centres
1.4.5 Retail Pharmacies
1.5 Global Obesity Management 麻豆原创 Size & Forecast
1.6 Global Obesity Management 麻豆原创 Size and Forecast by Region
1.6.1 Global Obesity Management 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Obesity Management 麻豆原创 Size by Region, (2019-2030)
1.6.3 North America Obesity Management 麻豆原创 Size and Prospect (2019-2030)
1.6.4 Europe Obesity Management 麻豆原创 Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Obesity Management 麻豆原创 Size and Prospect (2019-2030)
1.6.6 South America Obesity Management 麻豆原创 Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Obesity Management 麻豆原创 Size and Prospect (2019-2030)
2 Company Profiles
2.1 Allergan
2.1.1 Allergan Details
2.1.2 Allergan Major Business
2.1.3 Allergan Obesity Management Product and Solutions
2.1.4 Allergan Obesity Management Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.1.5 Allergan Recent Developments and Future Plans
2.2 Allurion Technologies
2.2.1 Allurion Technologies Details
2.2.2 Allurion Technologies Major Business
2.2.3 Allurion Technologies Obesity Management Product and Solutions
2.2.4 Allurion Technologies Obesity Management Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.2.5 Allurion Technologies Recent Developments and Future Plans
2.3 Arena Pharmaceuticals
2.3.1 Arena Pharmaceuticals Details
2.3.2 Arena Pharmaceuticals Major Business
2.3.3 Arena Pharmaceuticals Obesity Management Product and Solutions
2.3.4 Arena Pharmaceuticals Obesity Management Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.3.5 Arena Pharmaceuticals Recent Developments and Future Plans
2.4 Beijing Noble Laser Technology
2.4.1 Beijing Noble Laser Technology Details
2.4.2 Beijing Noble Laser Technology Major Business
2.4.3 Beijing Noble Laser Technology Obesity Management Product and Solutions
2.4.4 Beijing Noble Laser Technology Obesity Management Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.4.5 Beijing Noble Laser Technology Recent Developments and Future Plans
2.5 Eisai
2.5.1 Eisai Details
2.5.2 Eisai Major Business
2.5.3 Eisai Obesity Management Product and Solutions
2.5.4 Eisai Obesity Management Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.5.5 Eisai Recent Developments and Future Plans
2.6 GlaxoSmithKline
2.6.1 GlaxoSmithKline Details
2.6.2 GlaxoSmithKline Major Business
2.6.3 GlaxoSmithKline Obesity Management Product and Solutions
2.6.4 GlaxoSmithKline Obesity Management Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.6.5 GlaxoSmithKline Recent Developments and Future Plans
2.7 Johnson & Johnson
2.7.1 Johnson & Johnson Details
2.7.2 Johnson & Johnson Major Business
2.7.3 Johnson & Johnson Obesity Management Product and Solutions
2.7.4 Johnson & Johnson Obesity Management Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.7.5 Johnson & Johnson Recent Developments and Future Plans
2.8 Medtronic
2.8.1 Medtronic Details
2.8.2 Medtronic Major Business
2.8.3 Medtronic Obesity Management Product and Solutions
2.8.4 Medtronic Obesity Management Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.8.5 Medtronic Recent Developments and Future Plans
2.9 Nalpropion Pharmaceuticals
2.9.1 Nalpropion Pharmaceuticals Details
2.9.2 Nalpropion Pharmaceuticals Major Business
2.9.3 Nalpropion Pharmaceuticals Obesity Management Product and Solutions
2.9.4 Nalpropion Pharmaceuticals Obesity Management Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.9.5 Nalpropion Pharmaceuticals Recent Developments and Future Plans
2.10 Novo Nordisk
2.10.1 Novo Nordisk Details
2.10.2 Novo Nordisk Major Business
2.10.3 Novo Nordisk Obesity Management Product and Solutions
2.10.4 Novo Nordisk Obesity Management Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.10.5 Novo Nordisk Recent Developments and Future Plans
2.11 Obalon Therapeutics
2.11.1 Obalon Therapeutics Details
2.11.2 Obalon Therapeutics Major Business
2.11.3 Obalon Therapeutics Obesity Management Product and Solutions
2.11.4 Obalon Therapeutics Obesity Management Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.11.5 Obalon Therapeutics Recent Developments and Future Plans
2.12 Orexigen Therapeutics
2.12.1 Orexigen Therapeutics Details
2.12.2 Orexigen Therapeutics Major Business
2.12.3 Orexigen Therapeutics Obesity Management Product and Solutions
2.12.4 Orexigen Therapeutics Obesity Management Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.12.5 Orexigen Therapeutics Recent Developments and Future Plans
2.13 ReShape Lifesciences
2.13.1 ReShape Lifesciences Details
2.13.2 ReShape Lifesciences Major Business
2.13.3 ReShape Lifesciences Obesity Management Product and Solutions
2.13.4 ReShape Lifesciences Obesity Management Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.13.5 ReShape Lifesciences Recent Developments and Future Plans
2.14 Roche
2.14.1 Roche Details
2.14.2 Roche Major Business
2.14.3 Roche Obesity Management Product and Solutions
2.14.4 Roche Obesity Management Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.14.5 Roche Recent Developments and Future Plans
2.15 VIVUS
2.15.1 VIVUS Details
2.15.2 VIVUS Major Business
2.15.3 VIVUS Obesity Management Product and Solutions
2.15.4 VIVUS Obesity Management Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.15.5 VIVUS Recent Developments and Future Plans
3 麻豆原创 Competition, by Players
3.1 Global Obesity Management Revenue and Share by Players (2019-2024)
3.2 麻豆原创 Share Analysis (2023)
3.2.1 麻豆原创 Share of Obesity Management by Company Revenue
3.2.2 Top 3 Obesity Management Players 麻豆原创 Share in 2023
3.2.3 Top 6 Obesity Management Players 麻豆原创 Share in 2023
3.3 Obesity Management 麻豆原创: Overall Company Footprint Analysis
3.3.1 Obesity Management 麻豆原创: Region Footprint
3.3.2 Obesity Management 麻豆原创: Company Product Type Footprint
3.3.3 Obesity Management 麻豆原创: Company Product Application Footprint
3.4 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 麻豆原创 Size Segment by Type
4.1 Global Obesity Management Consumption Value and 麻豆原创 Share by Type (2019-2024)
4.2 Global Obesity Management 麻豆原创 Forecast by Type (2025-2030)
5 麻豆原创 Size Segment by Application
5.1 Global Obesity Management Consumption Value 麻豆原创 Share by Application (2019-2024)
5.2 Global Obesity Management 麻豆原创 Forecast by Application (2025-2030)
6 North America
6.1 North America Obesity Management Consumption Value by Type (2019-2030)
6.2 North America Obesity Management Consumption Value by Application (2019-2030)
6.3 North America Obesity Management 麻豆原创 Size by Country
6.3.1 North America Obesity Management Consumption Value by Country (2019-2030)
6.3.2 United States Obesity Management 麻豆原创 Size and Forecast (2019-2030)
6.3.3 Canada Obesity Management 麻豆原创 Size and Forecast (2019-2030)
6.3.4 Mexico Obesity Management 麻豆原创 Size and Forecast (2019-2030)
7 Europe
7.1 Europe Obesity Management Consumption Value by Type (2019-2030)
7.2 Europe Obesity Management Consumption Value by Application (2019-2030)
7.3 Europe Obesity Management 麻豆原创 Size by Country
7.3.1 Europe Obesity Management Consumption Value by Country (2019-2030)
7.3.2 Germany Obesity Management 麻豆原创 Size and Forecast (2019-2030)
7.3.3 France Obesity Management 麻豆原创 Size and Forecast (2019-2030)
7.3.4 United Kingdom Obesity Management 麻豆原创 Size and Forecast (2019-2030)
7.3.5 Russia Obesity Management 麻豆原创 Size and Forecast (2019-2030)
7.3.6 Italy Obesity Management 麻豆原创 Size and Forecast (2019-2030)
8 Asia-Pacific
8.1 Asia-Pacific Obesity Management Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Obesity Management Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Obesity Management 麻豆原创 Size by Region
8.3.1 Asia-Pacific Obesity Management Consumption Value by Region (2019-2030)
8.3.2 China Obesity Management 麻豆原创 Size and Forecast (2019-2030)
8.3.3 Japan Obesity Management 麻豆原创 Size and Forecast (2019-2030)
8.3.4 South Korea Obesity Management 麻豆原创 Size and Forecast (2019-2030)
8.3.5 India Obesity Management 麻豆原创 Size and Forecast (2019-2030)
8.3.6 Southeast Asia Obesity Management 麻豆原创 Size and Forecast (2019-2030)
8.3.7 Australia Obesity Management 麻豆原创 Size and Forecast (2019-2030)
9 South America
9.1 South America Obesity Management Consumption Value by Type (2019-2030)
9.2 South America Obesity Management Consumption Value by Application (2019-2030)
9.3 South America Obesity Management 麻豆原创 Size by Country
9.3.1 South America Obesity Management Consumption Value by Country (2019-2030)
9.3.2 Brazil Obesity Management 麻豆原创 Size and Forecast (2019-2030)
9.3.3 Argentina Obesity Management 麻豆原创 Size and Forecast (2019-2030)
10 Middle East & Africa
10.1 Middle East & Africa Obesity Management Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Obesity Management Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Obesity Management 麻豆原创 Size by Country
10.3.1 Middle East & Africa Obesity Management Consumption Value by Country (2019-2030)
10.3.2 Turkey Obesity Management 麻豆原创 Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Obesity Management 麻豆原创 Size and Forecast (2019-2030)
10.3.4 UAE Obesity Management 麻豆原创 Size and Forecast (2019-2030)
11 麻豆原创 Dynamics
11.1 Obesity Management 麻豆原创 Drivers
11.2 Obesity Management 麻豆原创 Restraints
11.3 Obesity Management Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Obesity Management Industry Chain
12.2 Obesity Management Upstream Analysis
12.3 Obesity Management Midstream Analysis
12.4 Obesity Management Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Allergan
Allurion Technologies
Arena Pharmaceuticals
Beijing Noble Laser Technology
Eisai
GlaxoSmithKline
Johnson & Johnson
Medtronic
Nalpropion Pharmaceuticals
Novo Nordisk
Obalon Therapeutics
Orexigen Therapeutics
ReShape Lifesciences
Roche
VIVUS
听
听
*If Applicable.
